Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
42.6M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
39.6K
-
Shares change
-
+29.8K
-
Total reported value, excl. options
-
$289K
-
Value change
-
+$171K
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$7.30
Significant Holders of Repare Therapeutics Inc. - Common Shares, no par value (RPTX) as of Q4 2023
2 filings reported holding RPTX - Repare Therapeutics Inc. - Common Shares, no par value as of Q4 2023.
Repare Therapeutics Inc. - Common Shares, no par value (RPTX) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.6K shares
of 42.6M outstanding shares and own 0.09% of the company stock.
Largest 10 shareholders include BVF INC/IL (10.3M shares), ORBIMED ADVISORS LLC (3.32M shares), Blue Owl Capital Holdings LP (3.12M shares), Deep Track Capital, LP (2.99M shares), ARK Investment Management LLC (2.82M shares), Versant Venture Management, LLC (2.65M shares), MPM ASSET MANAGEMENT LLC (2.24M shares), Redmile Group, LLC (2.15M shares), MPM BioImpact LLC (1.64M shares), and Artal Group S.A. (700K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.